IMARC Group, a leading market research company, has recently releases report titled “Synthetic Biology Market Report by Product (Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-nucleic Acids, Chassis Organism), Technology (NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, and Others), Application (Healthcare, Non-Healthcare), and Region 2024-2032” Offers a comprehensive analysis of the industry, which comprises insights on the global synthetic biology market.

How Big is the Synthetic Biology Market?

The global synthetic biology market size reached US$ 16.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 62.0 Billion by 2032, exhibiting a growth rate (CAGR) of 15.9% during 2024-2032.

Industry Overview of Synthetic Biology

Synthetic biology is the science of designing and engineering biological systems. It empowers scientists to create new life forms, redesign existing organisms, and engineer biological parts for specific functions. By amalgamating biology with engineering principles, synthetic biology opens a gateway to creating novel drugs, biofuels, sustainable materials, and tailored organisms to address various challenges. It not only paves the way for innovative solutions but also captures the imagination of businesses looking to harness its vast commercial potential.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/synthetic-biology-market/requestsample

What are the growth prospects and trends in the synthetic biology industry?

The growing demand for sustainable solutions represents one of the key factors offering a favorable market outlook. As businesses and consumers are prioritizing eco-friendly alternatives, synthetic biology offers a unique opportunity to develop renewable resources, such as biofuels and biodegradable materials.

Moreover, the healthcare sector is witnessing a surge in synthetic biology applications, with the development of custom-designed therapeutic agents and gene therapies. Additionally, the convergence of artificial intelligence (AI) and synthetic biology is unlocking unprecedented possibilities. AI-driven design and analysis are accelerating the creation of synthetic organisms, optimizing their functions, and reducing development timelines.

This synergy is providing profound implications for pharmaceutical companies, enabling them to expedite drug discovery and manufacturing processes. Furthermore, the accessibility of genetic editing tools like CRISPR-Cas9 is democratizing the field, allowing startups and established players to participate in the synthetic biology revolution.

Leading Companies Operating in the Global Synthetic Biology Industry:

  • Agilent Technologies Inc.
  • Amyris Inc.
  • Codexis Inc.
  • Danaher Corporation
  • Eurofins Scientific
  • GenScript Biotech Corporation
  • Illumina Inc.
  • Merck KGaA
  • New England Biolabs
  • Synthego Corporation
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience
  • Viridos Inc.

Synthetic Biology Market Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product:

  • Oligonucleotide/Oligo Pools and Synthetic DNA
  • Enzymes
  • Cloning Technologies Kits
  • Xeno-nucleic Acids
  • Chassis Organism

Breakup by Technology:

  • NGS Technology
  • PCR Technology
  • Genome Editing Technology
  • Bioprocessing Technology
  • Others

Breakup by Application:

  • Healthcare
    • Clinical
    • Non-Clinical/Research
  • Non-Healthcare
    • Biotech Crops
    • Specialty Chemicals
    • Bio-Fuels
    • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163